Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Co-Diagnostics Files to Sell Up to $25M in Stock

Co-Diagnostics Files to Sell Up to $25M in Stock

Aug 21, 2018
|
staff reporter

NEW YORK (GenomeWeb) — Co-Diagnostics announced today that it has filed with the US Securities and Exchange Commission to sell up to $25 million of its shares.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Molecular Diagnostics

  1. BARDA Exercises $10.5M Option on T2 Bio Contract

  2. PerkinElmer Newborn Screening Assay Receives CE-IVD Mark

  3. Fluidigm Finalizes $34M NIH Contract for SARS-CoV-2 Assay Production

  4. Diagnostic Firms' Stocks Continue Rollercoaster Ride as 360Dx Index Bounces Back 5 Percent

  5. Access Genetics Nabs Amended FDA Emergency Use Authorization for Oral Rinse SARS-CoV-2 PCR Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.